We are live on ! Find out more
INFI

Infinity Pharmaceuticals, Inc.
INFI

Delisted

INFI was delisted on the 13th of September, 2023.

Back to rankings

63 hedge funds and large institutions have $58.1M invested in Infinity Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 17 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,771% more call options, than puts

Call options by funds: $131K | Put options by funds: $7K

60% more capital invested

Capital invested by funds: $36.3M → $58.1M (+$21.8M)

2% less funds holding

Funds holding: 64 → 63 (-1)

10% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 10

18% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 17

Holders
63
Holders Change
-1
Holders Change %
-1.56%
% of All Funds
1.36%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
9
Increased
14
Reduced
17
Closed
10
Calls
$131K
Puts
$7K
Net Calls
+$124K
Net Calls Change
-$65K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$264K
2
BCM
Bridgeway Capital Management
Texas
+$239K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$118K
4
Renaissance Technologies
Renaissance Technologies
New York
+$101K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$91.9K

Top Sellers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
-$346K
2
OAM
Oxford Asset Management
United Kingdom
-$134K
3
Two Sigma Investments
Two Sigma Investments
New York
-$71.3K
4
Citadel Advisors
Citadel Advisors
Florida
-$51.4K
5
AIM
Alambic Investment Management
California
-$46K
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$32.8M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$4.35M +$264K +180,745 +8%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$2.93M – – –
PIM
4
Platinum Investment Management
Australia
$2.14M – – –
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$2.05M -$14.3K -9,766 -0.9%
BlackRock
6
BlackRock
New York
$1.83M -$8.17K -5,585 -0.6%
Renaissance Technologies
7
Renaissance Technologies
New York
$1.68M +$101K +69,300 +8%
BBA
8
Baker Bros. Advisors
New York
$1.09M – – –
Acadian Asset Management
9
Acadian Asset Management
Massachusetts
$1.02M +$88.3K +60,383 +13%
First Eagle Investment Management
10
First Eagle Investment Management
New York
$940K – – –
BCM
11
Bridgeway Capital Management
Texas
$832K +$239K +163,500 +59%
JP Morgan Chase
12
JP Morgan Chase
New York
$806K -$24.3K -16,596 -4%
FI
13
Fosun International
China
$786K +$58.5K +40,000 +11%
OAM
14
Oxford Asset Management
United Kingdom
$762K -$134K -91,615 -18%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$665K – – –
Jacobs Levy Equity Management
16
Jacobs Levy Equity Management
New Jersey
$361K +$91.9K +62,800 +49%
Northern Trust
17
Northern Trust
Illinois
$320K -$173 -118 -0.1%
QI
18
QS Investors
New York
$296K – – –
T. Rowe Price Associates
19
T. Rowe Price Associates
Maryland
$226K – – –
EWM
20
Evercore Wealth Management
New York
$223K – – –
Millennium Management
21
Millennium Management
New York
$213K +$63.6K +43,493 +62%
California Public Employees Retirement System
22
California Public Employees Retirement System
California
$166K – – –
Wells Fargo
23
Wells Fargo
California
$161K -$6.73K -4,602 -5%
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$151K +$118K +80,328 New
CHAM
25
Clear Harbor Asset Management
Connecticut
$136K -$3.66K -2,500 -3%
1
2 3

INFI Hedge Fund Activity: Q1 2019 in Review

63 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q1 2019, worth a combined $58.1M — up 60% from $36.3M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of INFI and 9 opened new positions — a net loss of 1 holder — while 17 trimmed existing stakes and 14 added.

The largest buyer was Vanguard Group, adding an estimated $264K. The largest seller was Anson Funds Management, exiting entirely with an estimated $346K sold.

  • 63 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q1 2019, down from 64 in Q4 2018.
  • Funds reported $58.1M of Infinity Pharmaceuticals, Inc. stock for Q1 2019, up 60% quarter-over-quarter.
  • 9 funds opened new Infinity Pharmaceuticals, Inc. positions in Q1 2019 and 10 closed out, a net change of -1 holder.
  • The largest Infinity Pharmaceuticals, Inc. buyer in Q1 2019 was Vanguard Group, an estimated $264K added.
  • The largest Infinity Pharmaceuticals, Inc. seller in Q1 2019 was Anson Funds Management, an estimated $346K sold.

Based on aggregated 13F filings for Q1 2019.